J 2024

Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022

SALMANTON-GARCIA, Jon, Francesco MARCHESI, Francesca FARINA, Barbora WEINBERGEROVÁ, Federico ITRI et. al.

Základní údaje

Originální název

Decoding the historical tale: COVID-19 impact on haematological malignancy patients-EPICOVIDEHA insights from 2020 to 2022

Autoři

SALMANTON-GARCIA, Jon, Francesco MARCHESI, Francesca FARINA, Barbora WEINBERGEROVÁ (203 Česká republika, domácí), Federico ITRI, Julio DAVILA-VALLS, Sonia MARTIN-PEREZ, Andreas GLENTHOJ, Ditte Stampe HERSBY, Da Silva Maria GOMES, Raquel Nunes RODRIGUES, Alberto LOPEZ-GARCIA, Raul CORDOBA, Yavuz M BILGIN, Iker FALCES-ROMERO, Shaimaa EL-ASHWAH, Ziad EMARAH, Caroline BESSON, Milena KOHN, Van Doesum JAAP, Emanuele AMMATUNA, Monia MARCHETTI, Jorge LABRADOR, Giovanni Paolo Maria ZAMBROTTA, Luisa VERGA, Ozren JAKSIC, Marcio NUCCI, Klara PIUKOVICS, Alba CABIRTA-TOUZON, Moraima JIMENEZ, Elena ARELLANO, Ildefonso ESPIGADO, Ola BLENNOW, Anna NORDLANDER, Stef MEERS, Jens Vian PRAET, Francesco Aiello TOMMASO, Carolina GARCIA-VIDAL, Nicola S FRACCHIOLLA, Mariarita SCIUME, Guldane Cengiz SEVAL, Pavel ZAK, Caterina BUQUICCHIO, Carlo TASCINI, Stefanie K GRAEFE, Martin SCHOENLEIN, Tatjana ADZIC-VUKICEVIC, Valentina BONUOMO, Chiara CATTANEO, Summiya NIZAMUDDIN, Martin CERNAN, Gaetan PLANTEFEVE, Romane PRIN, Tomas SZOTKOVSKI, Graham P COLLINS, Michelina DARGENIO, Verena PETZER, Dominik WOLF, Natasha COLOVIC, Lucia PREZIOSO, Toni VALKOVIC, Francesco PASSAMONTI, Gustavo-Adolfo MENDEZ, Uluhan SILI, Antonio VENA, Martina BAVASTRO, Alessandro LIMONGELLI, Rafael F DUARTE, Marie-Pierre LEDOUX, Milche CVETANOSKI, Zlate STOJANOSKI, Marina MACHADO, Josip BATINIC, Gabriele MAGLIANO, Monika M BIERNAT, Nikola PANTIC, Christian Bjorn POULSEN, Annarosa CUCCARO, Del Principe Maria ILARIA, Austin KULASEKARARAJ, Irati ORMAZABAL-VELEZ, Alessandro BUSCA, Fatih DEMIRKAN, Marriyam IJAZ, Nikolai KLIMKO, Igor STOMA, Sofya KHOSTELIDI, Noemi FERNANDEZ, Ali S OMRANI, Rui BERGANTIM, De Jonge NICK, Guillemette FOUQUET, Milan NAVRATIL, Ghaith ABU-ZEINAH, Michail SAMARKOS, Johan MAERTENS, De Ramon CRISTINA, Anna GUIDETTI, Ferenc MAGYARI, Tomas Jose GONZALEZ-LOPEZ, Tobias LAHMER, Olimpia FINIZIO, Natasha ALI, Laszlo Imre PINCZES, Esperanza LAVILLA-RUBIRA, Alessandra ROMANO, Maria MERELLI, Mario DELIA, Maria CALBACHO, Joseph MELETIADIS, Darko ANTIC, Jose-Angel HERNANDEZ-RIVAS, De Almeida Joyce MARQUES, Murtadha AL-KHABORI, Martin HOENIGL, Maria Chiara TISI, Nina KHANNA, Aleksandra BARAC, Noha EISA, Di Blasi ROBERTA, Raphael LIEVIN, Carolina MIRANDA-CASTILLO, Nathan C BAHR, Sylvain LAMURE, Mario Virgilio PAPA, Ayel YAHYA, Avinash AUJAYEB, Jan NOVAK, Nurettin ERBEN, Maria FERNANDEZ-GALAN, Susana Jose-Maria RIBERA-SANTA, Ikhwan RINALDI, Rita FAZZI, Monica PIEDIMONTE, Remy DULERY, Yung GONZAGA, Andres SOTO-SILVA, Giuseppe SAPIENZA, Alexandra SERRIS, Lubos DRGONA, Ana GROH, Laura SERRANO, Eleni GAVRIILAKI, Athanasios TRAGIANNIDIS, Juergen PRATTES, Nicola COPPOLA, Vladimir OTASEVIC, Milos MLADENOVIC, Mirjana MITROVIC, Bojana MISKOVIC, Pavel JINDRA, Sofia ZOMPI, Maria Vittoria SACCHI, Carolin KREKELER, Evgenii SHUMILOV, Stefania Infante MARIA, Daniel GARCIA-BORDALLO, Gokce Melis COLAK, Antonella CINGOLANI, Jiri MAYER, Marianna CRISCUOLO, Marietta NYGAARD, Michaela HANAKOVA, Luana FIANCHI, Zdeněk RÁČIL (203 Česká republika, domácí), Antonio GIORDANO, Martina QUATTRONE, Matteo BONANNI, Philipp KOEHLER, Laman RAHIMLI, Oliver A CORNELY a Livio PAGANO

Vydání

EClinicalMedicine, AMSTERDAM, ELSEVIER, 2024, 2589-5370

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30205 Hematology

Stát vydavatele

Nizozemské království

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 15.100 v roce 2022

Organizační jednotka

Lékařská fakulta

UT WoS

001311054400001

Klíčová slova anglicky

Vaccination; ICU; COVID-19; Haematological malignancy; Immunosuppression

Štítky

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 25. 10. 2024 11:24, Mgr. Tereza Miškechová

Anotace

V originále

Background The COVID-19 pandemic heightened risks for individuals with hematological malignancies due to compromised immune systems, leading to more severe outcomes and increased mortality. While interventions like vaccines, targeted antivirals, and monoclonal antibodies have been effective for the general population, their benefits for these patients may not be as pronounced.